To include your compound in the COVID-19 Resource Center, submit it here.

Atacand candesartan cilexetil: Completed Phase IIIb enrollment

AstraZeneca plc (AZN; LSE:AZN), London, U.K.
Product: Atacand candesartan cilexetil
Business: Cardiovascular
Therapeutic

Read the full 139 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE